| abstract |
The present invention provides a fixed dose combination dosage form for reducing cardiovascular metabolic risk. A fixed dose combination dosage form containing a biguanide compound, a statin, and an additional active agent. The additional active agent is selected from the group consisting of antihypertensive agents, antiplatelet agents, diuretics, bile acid scavengers, incretin mimetics and activators, antiobesity agents, oral antidiabetic agents, and antiatherosclerotic agents. Said combined dosage form. [Selection figure] None |